IGF1 LR3 from Canada Peptides is a modified molecule of an insulin-like growth factor of the Perov type, structurally similar to the protein of the insulin molecule, which has some insulin-like effects (in particular, acceleration of glucose utilization), but insulin itself is able to activate IGF-1 receptors, but 200 times worse than IGF itself.
IGF1 LR3 is a powerful anabolic agent that provides muscle growth, regeneration of any injuries and wounds, improved fat burning, normalization of internal organs and glands, improved immune system and accelerated recovery after physical overload.
Mechanism of action
IGF-1 LR3 belongs to a class of peptide compounds that are vital for the development of the body of any mammal. IGF1-LR3 differs from the natural peptide hormone in that the arginine molecule is replaced by glutamic acid in the third position in the sequence of the amino acid structure, but 13 more amino acids are added to the molecule at the N-end, resulting in 83 amino acids instead of 70 in the endogenous peptide hormone.
Thus, IGF-1 LR3 has the anabolic effect of the original peptide as an activator of the IGF-1 receptor, while it binds very poorly to insulin-like proteins (that is, it is constantly in free active form), improving metabolic stability. As a result, it is about three times more effective than conventional IGF-1, and its half-life is 20-30 hours (in IGF-1, it is 12-15 hours). IGF-1 LR3 mediates most of the work of growth hormone, that is, IGF-1 is produced in response to the introduction of growth hormone into the liver, and then acts on specific receptors, activating cell growth and other effects.
One such example is muscle growth and hyperplasia. And if mechanical growth factor (MGF) promotes an increase in the number of satellite cells, then it is IGF-1 that promotes the transformation of these cells into myocytes and further into new muscle cells, actually leading to an increase in the number of muscle fibers.
- accelerate the transfer of nutrients to the cells;
- hypertrophy of muscle fibers;
- hyperplasia of muscle fibers;
- improving the functioning of internal organs and glands;
- accelerate the regeneration of damaged tissues (damage to the skin, muscle tissue, joints and ligaments);
- improve the condition of the skin, hair and nails;
- improving the functioning of the thymus leads to the normalization of the immune system;
- acceleration of lipolysis.
It should be clarified that neither growth hormone nor IGF1 LR3 are the cause of the development of cancerous tumors, but if they are present (undiagnosed malignant or benign formations) these peptide compounds can accelerate their development, as they activate the growth of all cells in the body. Therefore, the athlete is recommended to undergo a full diagnosis to identify possible tumors. It is an effective tool for the growth of muscle fibers and the burning of adipose tissue.
Subcutaneous injection of IGF1 LR3 with an insulin syringe into the fold of the abdominal skin 1 time a day at a dose of 100 mcg, the course duration is 4-5 weeks.
The peptide is supplied as a powder, so it must be restored with bacteriostatic water, the water is injected with a regular intramuscular injection syringe through a rubber cap (it does not need to be removed from the bottle), and the water must flow down the wall of the bottle, and not directly into the drug (to avoid destroying the structure of the peptide). After that, wait until the drug itself is dissolved (it can not be shaken or shaken, as this will damage its structure). The drug should be stored in the refrigerator at a temperature of 2-8 degrees Celsius, it should not be exposed to direct sunlight or frozen.
IGF1 LR3 at the recommended dose, MGF-200-300 mcg in the target muscles after training (3 times a week), ACE-031 100 mcg per day.
Side effects of this drug may include: pain and redness at the injection site, decreased blood sugar, tunnel syndrome, accelerated growth of existing tumors (it is necessary to make a diagnosis before using the drug).